Practical Reviews

Novel TME-Based Risk Score Redefines Prognosis in CRC


Background: Conventional colorectal cancer (CRC) staging depends on the TNM system, yet clinical outcomes within the same stage remain significantly heterogeneous. Modern oncology emphasizes that the tumor microenvironment (TME) is a primary driver of invasion and metastasis. Beyond traditional markers like lymphovascular invasion, parameters such as tumor budding (TB), tumor-infiltrating lymphocytes (TILs), tumor–stroma ratio (TSR), and stromal maturity offer deeper insights into the biological behavior of the malignancy. Objective: To develop and validate a novel "Risk Score" classification system based on these 4 histopathological TME features to predict disease-free survival (DFS) and overall survival (OS) in primary operable CRC. Design: Retrospective study. Methods: This retrospective analysis was conducted on 499 Stage I to III CRC patients who underwent radical resection. These patients were randomized into training and validation cohorts. Pathologists blinded to clinic more...

Want to read the full article?

To view, you must be an active Practical Reviews subscriber.
Login or subscribe now.